
Sign up to save your podcasts
Or


With EMPACT-MI being presented at ACC, the definitive study of an additional agent (empagliflozin) will allow for a great discussion on options for patients who have acute MI and evidence of heart failure.
In this interview, Schuyler Jones, MD FACC, and Purvi Parwani, MBBS, MPH, FACC discuss Not the Same Old 5 Medications: Contemporary GDMT Algorithm in the Post-MI Patient.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
By American College of Cardiology3.8
5858 ratings
With EMPACT-MI being presented at ACC, the definitive study of an additional agent (empagliflozin) will allow for a great discussion on options for patients who have acute MI and evidence of heart failure.
In this interview, Schuyler Jones, MD FACC, and Purvi Parwani, MBBS, MPH, FACC discuss Not the Same Old 5 Medications: Contemporary GDMT Algorithm in the Post-MI Patient.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

518 Listeners

321 Listeners

504 Listeners

167 Listeners

906 Listeners

21 Listeners

31 Listeners

298 Listeners

3,374 Listeners

138 Listeners

1,150 Listeners

39 Listeners

367 Listeners

437 Listeners

32 Listeners